Depression-Focused GH Research Shares Could See Significant Upside: Analyst

benzinga.com/analyst-stock-ratings/initiation/25/10/48183784/depression-focused-gh-research-shares-could-see-significant-upside-analyst

Needham initiated coverage on Monday for GH Research PLC (NASDAQ:GHRS), citing the company’s lead drug candidate, GH-001, which had demonstrated impressive efficacy in Phase 2 versus competition.
• GHRS is showing upward movement. See the full breakdown here.
Recently, the company…

This story appeared on benzinga.com, 2025-10-13 18:07:06.
The Entire Business World on a Single Page. Free to Use →